COF vs LAB · P/E 62, rev $53.43B vs rev $174.4M
Capital One Financial Corporation (COF) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the COF and LAB stock pages for the full models.
Not investment advice.